PHEN,Inc. © 2021 All rights reserved
PHEN Mission & Initiatives
PHEN was founded in 2003 by Thomas A. Farrington, a prostate cancer survivor.
PHEN implements these national initiatives:
The PHEN Survivor Network was established in 2003 and is successfully mobilizing black prostate cancer survivors to work collectively towards eliminating the racial disparity.
Monthly Support Group Meetings and Webcasts since 2003 in partnership with the Dana-Farber Cancer Institute. The support group meetings bring survivors and their families together to learn about new prostate cancer developments, treatments and clinical trials. An educational presentation is streamed live for the public as a part of these meeting.
The "Annual African American Prostate Cancer Disparity Summit” began in 2005 to address policy, medical and community outreach initiatives to eliminate the prostate cancer racial disparity. It is a two-day program hosted in Washington, DC with live streaming.
PHEN Online Television began broadcasting in 2007 reaching men and their families at home with educational program content developed from PHEN's monthly meetings and summits and other relevant programs.
The "Annual Father's Day Rally" was launched in 2009 in partnership with churches nationwide who hold a special recognition and prayer for prostate cancer survivors and loved ones impacted by the disease during their Father's Day services.
PHEN's Educational Symposiums with Church Partners began in 2013 as an outgrowth of the Father's Day Rally. These symposiums are structured as four (4) hour events held at the facilities of PHEN church partners in different cities with medical specialists, community leaders and the public.
Monthly Treatments and Clinical Trials E-Newsletter began publication and distribution in 2012 to educate about evolving treatments and clinical trials to help keep the patient community knowledgeable in these areas which are critical to eliminating the disparity.
PHEN’s Clinical Trials Rally was launched in 2017 to raise the awareness and knowledge about prostate cancer clinical trials to increase African American participation.